⌘K

Login Start Free

Home/Filings/4/0001209191-22-035848

4//SEC Filing

Seehra Jasbir 4

Accession 0001209191-22-035848

CIK 0001664710other

View on SEC.gov Company Profile

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 4:12 PM ET

Size

6.9 KB

Accession

0001209191-22-035848

Insider Transaction Report

Form 4

Period: 2022-06-09

Keros Therapeutics, Inc.KROS

DirectorCHIEF EXECUTIVE OFFICER

Transactions

Exercise/Conversion
Employee Stock Option (right to buy)
2022-06-09−5,000→ 8,822 total
Exercise: $0.30Exp: 2028-03-25→ Common Stock (5,000 underlying)
Exercise/Conversion
Common Stock
2022-06-09$0.30/sh+5,000$1,500→ 248,856 total

Footnotes (1)

[F1]Fully vested and exercisable.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Keros Therapeutics, Inc.

CIK 0001664710

Entity typeother

Related Parties

1

filerCIK 0001732369

Filing Metadata

Form type: 4
Filed: Jun 9, 8:00 PM ET
Accepted: Jun 10, 4:12 PM ET
Size: 6.9 KB

View on SEC.gov